Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    LAVA Therapeutics N.V.

    NASDAQ: LVTX · Real-Time Price · USD
    1.32
    0.02 (1.54%)
    At close: Jun 06, 2025, 3:59 PM
    1.30
    -1.83%
    After-hours: Jun 06, 2025, 05:07 PM EDT

    LAVA Therapeutics Statistics

    Share Statistics

    LAVA Therapeutics has 26.31M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 26.31M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 24.11%

    Shares Floating

    n/a
    		 13.02M

    Failed to Deliver (FTD) Shares

    n/a
    		 674

    FTD / Avg. Volume

    n/a
    		 1.32%

    Short Selling Information

    The latest short interest is 88.99K, so 0.34% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 88.99K

    Short % of Shares Out

    n/a
    		 0.34%

    Short % of Float

    n/a
    		 0.55%

    Short Ratio (days to cover)

    n/a
    		 2.55

    Valuation Ratios

    The PE ratio is -1.02 and the forward PE ratio is -1.61. LAVA Therapeutics's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.02

    Forward PE

    n/a
    		 -1.61

    PS Ratio

    n/a
    		 2.13

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 0.92

    P/FCF Ratio

    n/a
    		 -1.3

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for LAVA Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.4, with a Debt / Equity ratio of 0.19.

    Current Ratio

    n/a
    		 4.4

    Quick Ratio

    n/a
    		 4.4

    Debt / Equity

    n/a
    		 0.19

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 -0.27

    Interest Coverage

    n/a
    		 -57.66

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $352,411.76

    Profits Per Employee

    n/a
    		 $-738,647.06

    Employee Count

    n/a
    		 34

    Asset Turnover

    n/a
    		 0.15

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 630K

    Effective Tax Rate

    n/a
    		 -2.57%

    Stock Price Statistics

    The stock price has increased by -42.36% in the last 52 weeks. The beta is 0.47, so LAVA Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.47

    52-Week Price Change

    n/a
    		 -42.36%

    50-Day Moving Average

    n/a
    		 1.26

    200-Day Moving Average

    n/a
    		 1.38

    Relative Strength Index (RSI)

    n/a
    		 55.34

    Average Volume (20 Days)

    n/a
    		 50,944

    Income Statement

    In the last 12 months, LAVA Therapeutics had revenue of 11.98M and earned -25.11M in profits. Earnings per share was -0.94.

    Revenue

    n/a
    		 11.98M

    Gross Profit

    n/a
    		 11.52M

    Operating Income

    n/a
    		 -29.69M

    Net Income

    n/a
    		 -25.11M

    EBITDA

    n/a
    		 -23.5M

    EBIT

    n/a
    		 -23.97M

    Earnings Per Share (EPS)

    n/a
    		 -0.94
    Full Income Statement

    Balance Sheet

    The company has 35.02M in cash and 5.28M in debt, giving a net cash position of 29.73M.

    Cash & Cash Equivalents

    n/a
    		 35.02M

    Total Debt

    n/a
    		 5.28M

    Net Cash

    n/a
    		 29.73M

    Retained Earnings

    n/a
    		 -174.97M

    Total Assets

    n/a
    		 71.16M

    Working Capital

    n/a
    		 59.41M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.54M and capital expenditures -23K, giving a free cash flow of -19.57M.

    Operating Cash Flow

    n/a
    		 -19.54M

    Capital Expenditures

    n/a
    		 -23K

    Free Cash Flow

    n/a
    		 -19.57M

    FCF Per Share

    n/a
    		 -0.73
    Full Cash Flow Statement

    Margins

    Gross margin is 96.1%, with operating and profit margins of -247.81% and -209.6%.

    Gross Margin

    n/a
    		 96.1%

    Operating Margin

    n/a
    		 -247.81%

    Pretax Margin

    n/a
    		 -204.34%

    Profit Margin

    n/a
    		 -209.6%

    EBITDA Margin

    n/a
    		 -196.14%

    EBIT Margin

    n/a
    		 -247.81%

    FCF Margin

    n/a
    		 -163.3%

    Dividends & Yields

    LVTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LVTX is $1.75, which is 32.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $1.75

    Price Target Difference

    n/a
    		 32.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.07

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist